Peaks of Interest
Sigma-Aldrich Corp. (St. Louis, Missouri) has acquired Pharmorphix, Ltd. (Cambridge, United Kingdom) that offers solid-form research services to pharmaceutical and biotech markets. Terms of the acquisition were not disclosed.
Sigma-Aldrich buys Pharmorphix
Sigma-Aldrich Corp. (St. Louis, Missouri) has acquired Pharmorphix, Ltd. (Cambridge, United Kingdom) that offers solid-form research services to pharmaceutical and biotech markets. Terms of the acquisition were not disclosed.
The company said that the addition of Pharmorphix will broaden its manufacturing services customer base and enhance technology offerings for existing customers.
The company said that Pharmorphix, which had sales of about $5 million in the past 12 months, would not have a material impact on its sales. Pharmorphix is expected to be neutral to mildly accretive to earnings in 2006, with no initial charges.
Airgas acquires Aeriform
Airgas, Inc. (Radnor, Pennsylvania) announced that it has reached a definitive agreement to acquire the assets and operations of Aeriform Corporation (Houston, Texas), an independent distributor with 29 locations in Texas, Louisiana, Oklahoma, and Kansas.
The operations to be acquired have about 240 employees and annual sales of approximately $65 million. About 58% of its revenue comes from gas and rent.
Airgas will integrate most of the operations into three of its regional companies: Airgas Southwest will integrate 14 sites in Texas, including locations near Houston, Victoria, El Paso, and Lubbock. Airgas Gulf States will integrate seven sites in southern Louisiana and east Texas. Airgas Mid South will integrate two sites in Kansas, and four sites in Oklahoma, and two locations in Shreveport, Louisiana.
Airgas will offer employment to most of the 240 employees of Aeriform affected by the acquisition.
Pittcon launches new web site for 2007
The Pittsburgh Conference (Pittsburgh, Pennsylvania) announced the launch of a redesigned web site for Pittcon 2007 (http://www.pittcon.org) with improved navigation enabling direct access to key information about the conference and expo and an improved appearance and design. The web site relays vital information to Pittcon conferees, exhibitors, and media representatives.
Other improvements to the site include an enhanced media center and the addition of an international travel section, a much requested photo gallery, brand manual, and a glossary of terms. The new site will be updated continually as new information regarding Pittcon 2007 becomes available.
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.
